Skip to main content
. 1998 Sep;153(3):973–983. doi: 10.1016/s0002-9440(10)65639-8

Figure 4.

Figure 4.

A: Disease-free survival of 109 breast cancer patients according to their tumor MRP-1/CD9 gene status. B: Overall survival of 109 breast cancer patients according to their tumor MRP-1/CD9 gene status. C: Disease-free survival of 109 breast cancer patients according to their tumor KAI1/CD82 gene status. D: Overall survival of 109 breast cancer patients according to their tumor KAI1/CD82 gene status. E: Disease-free survival of 109 breast cancer patients in relation to their classification (both MRP-1/CD9-positive and KAI1/CD82-positive subgroup versus either MRP-1/CD9-negative or KAI1/CD82-negative subgroup). F: Overall survival of 109 breast cancer patients in relation to their classification (both MRP-1/CD9-positive and KAI1/CD82-positive subgroup versus either MRP-1/CD9-negative or KAI1/CD82-negative subgroup).